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Abstract: After the diagnosis of a disease, one major objective is to predict cumulative probabilities of
events such as clinical relapse or death from the individual information collected up to a prediction time,
usually including biomarker repeated measurements. Several competing estimators have been proposed,
mainly from two approaches: joint modelling and landmarking. These approaches differ by the infor-
mation used, the model assumptions and the complexity of the computational procedures. This paper
aims to review the two approaches, precisely define the derived estimators of dynamic predictions and
compare their performances notably in case of misspecification. The ultimate goal is to provide key
elements for the use of individual dynamic predictions in clinical practice. Prediction of two competing
causes of prostate cancer progression from the history of prostate-specific antigen is used as a motivated
example. We formally define the quantity to estimate and its estimators, propose techniques to assess
the uncertainty around predictions and validate them. We then conduct an in-depth simulation study
compare the estimators in terms of prediction error, discriminatory power, efficiency and robustness to
model assumptions. We show that prediction tools should be handled with care, in particular by properly
specifying models and estimators.
Keywords: Competing risks; Dynamic Prediction; Landmarking; Joint modelling; Prediction accuracy;
Robustness.
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21 Introduction
After diagnosis and subsequent treatment of cancer, patients are typically monitored via repeated mea-
surements of biomarkers. For example, in patients with prostate cancer treated by radiotherapy, the
Prostate Specific Antigen (PSA) is measured routinely. Precisely predicting the individualized probabil-
ities of events such as clinical relapse for these patients from their individual information collected until
a prediction time has become a central issue (Goldstein et al., 2017; Proust-Lima and Taylor, 2009). Per-
sonalized treatment strategies can indeed be proposed according to the updated individual probabilities
(Se`ne et al., 2016), or the planning of the next biomarker measurement can be optimized (Rizopoulos
et al., 2015).
Two main approaches have been proposed to compute individual dynamic predictions: the joint
modelling approach and the landmarking approach. These techniques differ in the used information, the
model assumptions and the complexity of computational procedures.
The joint modelling (JM) approach simultaneously models the repeated measurements of a biomarker
(e.g., using a linear mixed model in standard JM) and time-to-event data (e.g., using a proportional haz-
ards model in standard JM) by linking them using a function of shared random effects (Tsiatis and
Davidian, 2004). This approach has the advantage of taking into account the endogenous nature of
biomarkers (Kalbfleisch and Prentice, 2011), of only requiring one model estimation for all prediction
times, and of modelling the progression of the disease as a whole, which makes it very popular. But it
is often based on simplifying assumptions (e.g., proportional hazards, number of random effects) and
may be complex to estimate, so that it should be handled carefully and can remain difficult to apply in
practice.
The landmarking approach consists of adjusting standard survival models considering only the sub-
sample of subjects still at risk at the prediction time and the longitudinal information collected up to
the prediction time (Van Houwelingen, 2007). Classically, the model is a Cox model (or cause-specific
proportional hazard model) with a truncation at the prediction time. As such, these models induce sig-
nificantly less numerical problems. In addition a censoring is usually administered at the end of the
prediction window to reduce possible bias related to the proportionality of hazards. However, as they
do not fully explore the collected information during the follow-up and the correlation between the
marker and the time of event, they can produce sub-efficient estimators (Huang et al., 2016) and are
only an approximation of the (correct) joint estimator. As explained in Suresh et al. (2017) Suresh et al.
(2017) they do not satisfy the consistency condition introduced by Jewell and Nielsen (1993) Jewell and
Nielsen (1993) which stipulates that the hazard function and the marker dynamics must be linked at all
time points to give consistent dynamic predictions. In the presence of a longitudinal biomarker, the naive
landmark approach consists in adjusting the survival model on the last observed value of the biomarker.
To take into account the measurement errors of the biomarker and its collection at discrete times, the
last observed value may be replaced by the predicted value at the prediction time obtained from a linear
mixed model (Rizopoulos et al., 2017; Sweeting et al., 2017). This two-stage approach also takes into
account all the collected information of the biomarker until the prediction time for the subjects at risk.
However the event probabilities must still be deduced by approximation and the model is not completely
freed of the proportional hazards assumption.
In the context of competing risks, instead of assuming a cause-specific proportional hazard model,
the conditional probabilities of event can be directly modelled by considering a dynamic pseudo-observations
approach (Nicolaie et al., 2013), which is freed from the proportionality hazards assumption. By includ-
ing the predicted value of the biomarker at the prediction time as a covariate, it also takes into account the
measurement errors of the biomarker and its collection in discrete time. But it requires the specification
3of a link function and can still provide less efficient estimators than the joint model.
Although of central interest in many recent works, there remains some vagueness in the definition of
estimators of dynamic predictions and of their uncertainty. Several definitions exist in the joint modelling
framework (Barrett and Su, 2017; Rizopoulos, 2011; Se`ne et al., 2016) and no concept of uncertainty
was introduced in the landmarking framework (Proust-Lima and Taylor, 2009; Rizopoulos et al., 2017;
Sweeting et al., 2017). Overall, estimators of dynamic predictions have never been formally validated
in simulations. We thus aimed to first define estimators of individual dynamic predictions, propose
estimators of their uncertainty with 95% confidence intervals for the joint modelling and the landmarking
approaches and validate them in a simulation study. We then aimed to compare the predictive accuracy
of the models under several scenarios to explore their robustness to misspecification. We used the
prediction of competing progressions of prostate cancer from the PSA history as the motivating and
illustrating example.
The rest of the paper is organized as follows. Section 2 introduces the concept of individual dynamic
prediction, the two modelling approaches and the derived estimators of dynamic predictions and of their
uncertainty. Section 3 describes the motivating data and gives an illustration of computed individual
dynamic predictions using landmark models or joint models. The simulation studies are carried out in
Section 4 for validating the proposed estimators and comparing them in terms of prediction accuracy.
The paper ends with a discussion and recommendations in Section 5.
2 Prediction models
Let us consider without loss of generality the setting where subjects are at risk to experience K competing
events. For each subject i (i = 1, ...,N), we denote Ti the earliest time-to-event and δi = k the cause of
failure (k ∈ 1, . . . ,K). In the presence of censoring, we observe the event time T †i = min(Ti,Ci) with Ci
the censoring time, and the indicator of event becomes ∆i = δi .1{Ti ≤ Ci} with 1 the indicator function.
We also observe Xi the (possibly time-dependent) exogenous covariates collected until the event time
and Yi an endogenous longitudinal marker repeatedly measured such as Yi(ti j) is the observed measure
at time ti j ( j = 1, ..., ni), with tini ≤ T †i .
In the following, Xi(s) denotes the history of Xi until time s, Yi(s) = {Yi(ti j) : 0 ≤ ti j ≤ s, j =
1, . . . , ni(s)} denotes the history of the marker until s, and the model formulations assume a Gaussian
distribution for the marker.
2.1 Definition of individual dynamic prediction
We are interested in the individual probability of experiencing event of cause k between times s and s+w
for a new subject ? conditional to the history X?(s) and Y?(s). Time s is called the landmark time (or
prediction time) and w the horizon of prediction. This probability is defined as
pik?(s,w) = Pr(s < T? ≤ s + w, δ? = k|T? > s,Y?(s),X?(s)). (1)
We focus on models that express this quantity as a function of a vector of parameters θ:
pik?(s,w; θ) = Pr(s < T? ≤ s + w, δ? = k|T? > s,Y?(s),X?(s); θ). (2)
In practice, θ is unknown and is replaced by θ̂I, its estimate from the considered observed data in
the learning sample I. In the remainder of the manuscript, this subscript is omitted for the sake of
readability, and the estimated quantity of interest is denoted p̂ik?(s,w; θ̂).
42.2 Joint model
2.2.1 Model formulation
The joint model considers the full collected information I = {(T †i ,∆i,Yi(T †i ),Xi(T †i )); i = 1, . . . ,N}. It
is decomposed into two sub-models linked by a function of a shared latent structure. The most popular
joint model (Rizopoulos, 2011) links a linear mixed model for the repeated measurements of the marker
and a cause-specific proportional hazards model for the specific hazard of each cause k of event using a
function of shared random effects:
Yi(t) = mi(t) + i(t)
= XLi (t)
>β + Zi(t)>bi + i(t),
λki (t) = λk,0(t) exp
{
XE >k,i γk + Wk,i(t|bi; β)>ηk
}
,
where t > 0 and λki (t) denotes the hazard function of cause k at time t, with k = 1, . . . ,K. In the
longitudinal sub-part, XLi (t) and Zi(t) denote vectors of covariates (possibly time-dependent) associated
respectively with the vector of fixed effects β and the vector of random effects bi, bi ∼ Nq(0,D). The
error term is i(t) ∼ N(0, σ2) ; the random effects and error terms are independent. In the survival
sub-part, λk,0(t) denotes the parametric baseline hazard of cause k at time t. The vector of covariates XEk,i
is associated with the vector of coefficients γk. We do not consider here any time-dependent exogenous
prognostic variable although this is not a requirement. The (possibly multivariate) function Wk,i(t|bi; β)
denotes the function of dependence between the longitudinal process and the hazard of event of cause k.
Examples include the unbiased current level of the marker mi(t), the unbiased current slope ∂mi(t)/∂t or
both (mi(t), ∂mi(t)/∂t)>.
A joint model can be estimated in the maximum likelihood framework using the independence be-
tween the longitudinal process Yi(T †i ) and the survival process (T †i ,∆i) conditionally on the random
effects bi. The likelihood involves integrals over the random effects and time that have to be numerically
solved, usually using Gaussian quadratures (Rizopoulos, 2012). Note that the number of quadrature
points has to be chosen carefully to provide correct inference (Ferrer et al., 2016).
2.2.2 Cumulative probability estimator
Once the model is estimated, the vector of parameters θ̂ and its variance matrix V̂ (̂θ) are obtained, with
θ̂ = (̂β>, σ̂2, θ̂>λ0 , γ̂
>, η̂>, vec(D̂)>)>, where γ̂ = (̂γ1, . . . , γ̂K)>, η̂ = (̂η1, . . . , η̂K)> and θ̂λ0 = (̂λ1,0, . . . , λ̂K,0)>
denotes the parameters for the baseline hazards. The predicted conditional cumulative probability of
cause k can thus be computed for a new subject ? for any landmark time s and horizon w:
p̂ik?(s,w; θ̂) =∫
Rq
Pr(s < T? ≤ s + w, δ? = k|T? > s,X?(s), b?; θ̂) f (b?|T? > s,Y?(s),X?(s); θ̂) db?. (3)
The integral (3) is usually approximated by a Gaussian quadrature; we call this estimator the marginal
estimator. When approximated by a Laplace approximation, the estimator becomes the integrand com-
puted at the modal point; we refer to this faster but less accurate alternative as the conditional estimator.
See details on the marginal and conditional estimators in Sections 1.1 and 1.2 of the Supplementary
Material.
5As the model is fully parametric, the 95% confidence interval of (3) can be obtained using a para-
metric bootstrap technique. The procedure is realized as follows:
Consider a large L; for each l = 1, . . . , L,
1. generate parameters from their asymptotic distribution θ˜(l) ∼ N (̂θ, V̂ (̂θ));
2. compute the predicted probability p˜ik,(l)? (s,w; θ˜
(l)) defined in (3) for parameter values θ˜(l) instead
of θ̂.
Compute the 95% confidence interval from the 2.5th and 97.5th percentiles of {˜pik,(l)? (s,w; θ˜(l)); l =
1, . . . , L}.
2.3 Landmark cause-specific proportional hazards model
In contrast with joint models, landmark models only consider subjects at risk at a given landmark time s
and the longitudinal information {Y(s),X(s)} collected until s. When considering PH landmark models,
administrative censoring is applied at the end of the prediction window s + w in order to reduce the
possible bias entailed by a violation of the PH assumption. The considered information becomes I =
{(T †i (s,w),∆i(s,w),Yi(s),Xi(s)); i = 1, . . . ,N†(s)}, with T †i (s,w) = min(T †i , s + w), ∆i(s,w) = ∆i .1{s <
Ti ≤ s + w} and N†(s) = ∑Ni=1 1{T †i > s}.
2.3.1 Model formulation
The landmark cause-specific (CS) proportional hazards (PH) model is defined by
λki (t) = λk,0(t) exp
{
XE >k,i γk + Wk,i(s)
>ηk
}
,
where t > s, λk,0(.) is a cause-specific baseline hazard function (most often left unspecified) and Wk,i(s)
is a multivariate function that depicts the dynamics of the marker extrapolated at time s. When λk,0(.)
is left unspecified, as it is considered in the following, the model is estimated by maximizing the Cox
partial likelihood for each considered pair of landmark and horizon times. Note that for the sake of
clarity, we did not use a subscript s,w for the model parameters although they are different for each
(s,w).
To take into account the information of the marker before landmark time s, one can consider the
last observed value only, i.e. Wk,i(s) = Yi(tini(s)). However, this technique, called naive landmark model
assumes that the marker is measured without error and considers neither the whole trajectory of the
marker until s nor the subject-specific gap between tini(s) and s. A better alternative is to deduce the
value of Wk,i(s) at time s from a linear mixed model estimated on the marker measurements collected
until s in subjects at risk at s. This technique is called two-stage landmark model. For instance, by
considering the same notations as in Section 2.2.1 for the linear mixed model and the expected level of
the biomarker in s as the shared quantity, Wk,i(s) = Ŷi(s) = XLi (s)
>β̂ + Zi(s)>b̂i where β̂ is the vector
of estimated fixed effects and b̂i = E(bi|Yi(s),Xi(s); θ̂) = D̂Z>i V̂−1i (Yi − XLi β̂) is the vector of empirical
Bayes estimates of the individual random effects, with V̂i = ZiD̂Z>i + σ̂
2Ini(s). Here X
L
i and Zi are the
matrices of covariates with respectively the row vectors XLi (ti j)
> and Zi(ti j)>, and the column vector
Yi is with elements Yi j, for j = 1, . . . , ni(s). I is the identity matrix. More generally, in the two-stage
landmark model, the shared quantity is Wk,i(s) = Ŵk,i(s|̂bi; β̂).
62.3.2 Cumulative probability estimator
With the two-stage approach, the predicted conditional cumulative probability of cause k is
p̂ik?(s,w; θ̂) = Pr (s < T? ≤ s + w, δ? = k|T? > s,X?(s), b̂?; θ̂), (4)
where θ̂ = (̂β>, σ̂2, γ̂>, η̂>, vec(D̂)>)> is the vector of estimated parameters (with associated estimated
variance V̂ (̂θ)), and b̂? = E(b?|Y?(s),X?(s); θ̂).
To estimate valid 95% confidence intervals, it is necessary to take into account the variability due
to the parameters and baseline hazard estimates. The unspecified cumulative baseline hazard Λk,0(t) =
t∫
s
λk,0(u) du is estimated using the Breslow’s estimator (Breslow, 1972), Λ̂k,0(t) =
t∫
s
Π̂
(0)
k (̂θ, u)
−1 dJ¯k(u)
where Π̂(0)k (̂θ, u) =
1
N†(s)
N†(s)∑
i=1
1{T †i (s,w) ≥ u} exp
{
XE >k,i γ̂k + Ŵk,i(s|̂bi; β̂)>η̂k
}
and J¯k(u) =
1
N†(s)
N†(s)∑
i=1
1{T †i (s,w) ≤
u,∆i(s,w) = k}. We propose a procedure that combines parametric bootstrap to take into account the
variability associated to θ̂ and perturbation-resampling methods, inspired by Sinnott and Cai (2016)
Sinnott and Cai (2016), to take into account the variability associated to Λ̂k,0(.). Indeed, parametric
bootstrap does not apply to unspecified baseline risk functions.
This procedure, which also avoids hard computational cost, is realized as follows:
For each bootstrap sample l = 1, . . . , L, where L is large enough;
1. generate regression parameters from their asymptotic distribution θ˜(l) ∼ N (̂θ, V̂ (̂θ));
2. deduce the empirical Bayes estimates b̂(l). = E(b.|Y.(s),X.(s); θ˜(l));
3. generate a perturbation ν(l)i ∼ 4 · Beta(1/2, 3/2) for each subject i ∈ 1, . . . ,N†(s) of the learning
sample;
4. compute the Breslow’s estimator Λ˜(l)k,0(u) from the perturbed hazard and the perturbed proportion
of events at parameter values θ˜(l) and b̂(l). :
Π̂
(0),(l)
k (˜θ
(l), u) =
1
N†(s)
N†(s)∑
i=1
ν(l)i × 1{T †i (s,w) ≥ u} exp
{
XE >k,i γ˜
(l)
k + Ŵk,i(s|̂b(l)i ; β˜(l))>η˜(l)k
}
J¯(l)k (u) =
1
N†(s)
N†(s)∑
i=1
ν(l)i × 1{T †i (s,w) ≤ u,∆i(s,w) = k};
5. deduce the predicted probability p˜ik,(l)? (s,w; θ˜
(l)) as a function of θ˜(l), b̂(l)? and {(Λ˜(l)k,0(u), s < u ≤
s + w); k = 1, . . . ,K}. See details in Section 1.4 of the Supplementary Material.
Compute the 95% confidence interval from the 2.5th and 97.5th percentiles of {˜pik,(l)? (s,w; θ˜(l)); l =
1, . . . , L}.
7With the naive approach, the predicted conditional cumulative probability of cause k is
p̂ik?(s,w; θ̂) = Pr (s < T? ≤ s + w, δ? = k|T? > s, {XEk,?; k = 1, . . . ,K},Y?(t?n?(s)); θ̂) (5)
with θ̂ = (̂γ>, η̂>)>.
The same technique combining parametric bootstrap and perturbation-resampling can be used to obtain
95% confidence intervals.
2.4 Landmark model based on pseudo-observations
Cause-specific hazard models rely on the PH assumption and require the computation of integrals over
time in the individual cumulative probabilities. To avoid these issues, some authors have focused on the
direct modelling of the individual cumulative probabilities, as for example the pseudo-value approach
(Andersen and Pohar Perme, 2010). As the latter does not require the PH assumption, the considered
information is I = {(T †i ,∆i,Yi(s),Xi(s)); i = 1, . . . ,N†(s)}.
2.4.1 Model formulation
For subjects at risk at time s, we are interested in the expectation of µki (s,w) = 1(Ti ≤ s + w, δi =
k). In presence of censoring, this quantity is not always observable. Thus the idea is to define the
dynamic jackknife pseudo-observation (Nicolaie et al., 2013) of the non-parametric estimator of pik(s,w):
µ̂ki (s,w) = N
†(s)F̂k(s,w) − (N†(s) − 1)F̂k(−i)(s,w), where N†(s) is the number of subjects at risk at s and
F̂k(s,w) is the Aalen-Johansen estimate of pik(s,w).
To include the dynamic information on the marker until s, the same two-stage approach as defined
in Section 2.3 can be used to deduce Ŵk,i(s|̂bi; β̂) in those still at risk in s. The pseudo-observation and
the prognostic factors are then linked through a generalized linear model with link function g:
g
[
E{̂µki (s,w)|T †i > s}
]
= γ0,k + XE >k,i γ1,k + Ŵk,i(s|̂bi; β̂)>ηk.
The model is thus estimated using generalized estimating equations (GEE).
2.4.2 Cumulative probability estimator
The predicted conditional cumulative probability can be directly expressed as
p̂ik?(s,w; θ̂) = Pr (s < T? ≤ s + w, δ? = k|T? > s,X?(s), b̂?; θ̂), (6)
with b̂? = E(b?|Y?(s),X?(s); θ̂) and θ̂ = (̂β>, σ̂2, γ̂0,k, γ̂>1,k, η̂>k , vec(D̂)>)> the vector of estimated pa-
rameters (with associated estimated variance matrix V̂ (̂θ)). When considering the cloglog link function
(cloglog(x) = log{− log(1−x)}) for instance, the predicted probability is p̂ik?(s,w; θ̂) = 1−exp
[
−exp{̂γ0,k+
XE >k,i γ̂1,k + Ŵk,i(s|̂bi; β̂)>η̂k}
]
.
The 95% confidence intervals of (6) may be calculated using parametric bootstrap:
8Consider a large L; for each l = 1, . . . , L,
1. generate parameters from their asymptotic distribution θ˜(l) ∼ N (̂θ, V̂ (̂θ));
2. deduce the empirical Bayes estimates b̂(l)? = E(b?|Y?(s),X?(s); θ˜(l));
3. compute the predicted probability p˜ik,(l)? (s,w; θ˜
(l)) defined in (6) for parameter values θ˜(l) and
corresponding b̂(l)? .
Compute the 95% confidence interval from the 2.5th and 97.5th percentiles of {˜pik,(l)? (s,w; θ˜(l)); l =
1, . . . , L}.
2.5 Implementation
The estimation of prediction models and the computation of derived estimators were done in R us-
ing standard packages and extensions coded by the authors, with the JM package for joint models, the
survival package for the landmark cause-specific proportional hazards models and the pseudo and
geepack packages for landmark models based on pseudo-values. Examples of codes used for the sim-
ulations can be found in Supplementary Material, Section 5, and detailed examples can be found at
https://github.com/LoicFerrer/ for practical use.
3 Illustrative example in Prostate Cancer progression
We illustrate the computation of individual dynamic predictions in the context of localized Prostate
Cancer treated by external beam radiotherapy. The objective was to predict the risk of progression after
treatment from the prognosis factors collected at diagnosis (e.g., tumor stage) and the history of the
Prostate Specific Antigen (PSA), the central marker in Prostate Cancer, repeatedly collected after treat-
ment. We used the same data as analyzed in Ferrer et al. (2016) Ferrer et al. (2016) from the multi-center
clinical trial RTOG 9406 (USA) Michalski et al. (2005) and the cohort of the British Columbia Cancer
Agency in Vancouver (Canada) Pickles et al. (2003). Specifically, after the end of the radiotherapy,
repeated PSA measurements were collected until the occurrence of a disease recurrence (local/distant
recurrence, initiation of hormonal therapy or death due to prostate cancer) or death due to an other cause.
After radiotherapy, post-treatment PSA trajectory is mostly biphasic with a short term drop associated
with the treatment efficacy and possibly followed by a linear increase, associated with higher risk of
recurrence. Some authors showed in this context that including the post-treatment PSA dynamics in dy-
namic prediction tools of overall disease recurrence highly improved the prediction accuracy compared
to tools using only diagnosis information (Proust-Lima and Taylor, 2009; Taylor et al., 2013).
All the models considered a biphasic trajectory of PSA and competing risks of recurrence and of
death before recurrence. They were adjusted on the cohort (Cohort), age (Age), tumor stage (Tstage),
Gleason score (Gleason, which measures aggressiveness of the cancer) and pretreatment log PSA level
(Initial logPSA). The effect of the PSA dynamics on the specific hazards of recurrence and death was
summarized by the extrapolated level and slope of the PSA in the joint models and two-stage landmark
models.
We excluded two patients from the estimation sample and computed for them cumulative probabil-
9ities of having a prostate cancer recurrence in an horizon of 1.5 or 3 years from two landmark times.
The trajectories of PSA and estimated dynamic predictions are displayed in Figure 1 (Figure 1 of the
Supplementary Material displays the predictions for death without recurrence).
After one year and a half (1.3 years exactly for patient A), the two patients have roughly the same
PSA trajectory. Yet, their predicted probabilities of recurrence substantially differ: patient B has a
higher probability to progress than patient A; this is explained by worse prognostic factors at the end of
treatment (higher tumour stage, Gleason score and initial PSA level).
After one additional year, PSA trajectories strictly differ between the two patients: PSA has kept
going down for patient B while PSA has sharply increased for patient A. These results in an updated
predicted cumulative probabilities of recurrence systematically lower than 0.11 for patient B and sys-
tematically higher than 0.70 for patient A. In reality, patient A was diagnosed with a local recurrence
3 years after the end of radiotherapy while patient B was censored without any event after 13 years of
follow-up.
Predictions from all the models are roughly in accordance. However, we observe that point estimates
and width of confidence intervals substantially vary between models, especially when predictions are
high.
4 Simulation studies
Two simulation studies were performed, one for the validation of the estimators (Section 4.1), and a
second for their comparison and the assessment of their robustness to misspecification (Section 4.2).
Both simulation studies relied on the Prostate Cancer example of Section 3 to generate realistic data and
on the same following design.
R = 500 learning samples of N = 1000 subjects as well as one validation sample of Nnew(0) = 500
subjects were generated from a joint model with parameter values θ0 (Ferrer et al., 2016). The mod-
els detailed in Section 2 were estimated on each learning sample r (r = 1, ...,R) and the derived
estimators of cumulative probability were computed for a given horizon w on the Nnew(s) subjects
(? = 1, . . . ,Nnew(s)) of the validation sample who did not experience any event before landmark time
s. For each replicate r, we then compared the true generated cumulative probability pik?(s,w; θ0) =∫
Rq
pik?(s,w|b?; θ0) f (b?|T? > s,Y?(s),X?(s); θ0) db? with the estimators p̂ik?,r(s,w; θ̂).
4.1 Simulation study I : Validation of the estimators p̂ik?(s,w; θ̂)
We validated the estimators by checking the distributions over the individuals of estimated relative bias
and coverage rates for pik?(s,w; θ0). We also investigated their efficiency using the mean over the repli-
cates of the confidence interval widths.
4.1.1 Model specification
For each subject of the learning or validation sample, data were generated according to a joint model with
linear marker trajectory, true current level and true current slope of the marker as association structure
Wk,.(t|b., β), and two causes of event (Recurrence ; Death). The model formulation is given in Sup-
plementary Material, Section 3.1. The coefficients and covariate distributions used in the simulations
correspond to those obtained on the motivating data.
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4.1.2 Results
Due to the duration of the procedures, the simulations were run for two landmark times s = 1 and s = 5,
one horizon time w = 3 and 200 subjects randomly selected from the validation sample. R = 499 and
R = 486 replicates were considered for s = 1 and s = 5 respectively, due to convergence problems in
the landmark model estimation.
Figures 2a and 2b depict respectively the distribution over the subjects of the relative bias of the
estimator and the coverage rates of its 95% confidence interval both for the joint and two-stage landmark
CS PH models for landmark times s = 1 and s = 5 and one horizon time w = 3. The box plots highlight
the correct estimation of pik?(s,w; θ0), except for the conditional expression from the joint model in the
earlier landmark times (s = 1). This confirms that considering the modes of the posterior distributions
of the random effects (see Supplementary Material, Section 1.2) is valid only when there is enough
longitudinal information. The coverage rates which are very close to 0.95 validate the proposed 95%
confidence interval computations for both approaches. Finally the comparison of the widths of the 95%
confidence intervals according to the joint and two-stage landmark CS PH models (Figure 2c) confirms
that the joint model estimator is much more efficient than the landmark CS PH estimator.
4.2 Simulation study II : Robustness to models hypotheses
The second simulation study aimed to compare the robustness of the approaches to model misspeci-
fication. We relied for this on predictive accuracy on the validation sample with both the Area Un-
der the ROC curve (AUC) and the Mean Squared Error of Prediction (MSEP) popularized through
the Brier Score (BS). Since we were in a simulation study, rather than using the event indicator and
computing the BS, we directly used the true generated individual prediction and computed the MSEP:
MSEPkr(s,w) =
1
Nnew(s)
×
Nnew(s)∑
?=1
(
pik?(s,w; θ0) − p̂ik?,r(s,w; θ̂)
)2
. For the AUC, we applied the defini-
tion adapted to the competing risks setting (Blanche et al., 2015): AUCkr(s,w) = Pr (̂pi
k
i,r(s,w; θ̂) >
p̂ikj,r(s,w; θ̂) |∆ki (s,w) = 1,Ti > s,∆kj(s,w) = 0,T j > s), where ∆ki (s,w) = 1{s < Ti ≤ s + w, δi = k}
with δi = k the cause of event ; i and j are here two subjects for prediction (see Supplementary Material
2.2 for details on the AUC formulation). Note that both AUC and MSEP estimators were intrinsically
model free since we were in a simulation study and did not have to deal with censoring.
We considered four scenarios: (1) correct specification of the joint model, (2) misspecification of
the dependence function, (3) violation of the proportional hazards assumption, and (4) misspecification
of the longitudinal trajectory of the marker. The distribution of the covariates and the coefficients used
for the generation data in the four cases can be found in Supplementary Material, Section 3. Under
each scenario, for the sake of scale and readability of the results, we chose to display boxplots of the
differences in the predictive accuracy measures over the R replicates to compare prediction models two
by two; mean absolute measures are indicated for the marginal estimator taken as the reference in the
comparisons. We focused on the error or prediction with MSEP in the main manuscript (Figures 3 to
6) as it assesses both calibration and discrimination abilities of the methods. Results on AUC (which
only focuses on discrimination ability and as such neglects an important aspect of predictive accuracy
(Blanche et al., 2015)) are provided in Supplementary Material (Figures 6 to 10).
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4.2.1 Case 1: Correct specification of the joint model
For the well-specified case, data generation and specification of the joint and landmark models in the
estimation and prediction steps were the same as in Section 4.1.
Figure 3 shows differences of MSEP for 8 pairs of landmark and horizon times (s = 1, 3, 5, 8 and
w = 1.5, 3). As expected, the joint model performed better than the landmark models for all the pairs
(s,w). Once again, the conditional estimator of the predicted probability in the joint model was much
worse than its marginal alternative in the earliest landmark times, but gave similar performances from
s = 5. When assessing discriminatory power with AUC (Figure 6 in Supplementary Material), the joint
model still performed better than landmark models, especially the naive landmark model. However, no
difference was highlighted between the conditional and marginal estimators suggesting a problem of
calibration rather than discrimination for the conditional estimator in the earliest times. It can be noted
that most of the convergence problems in the model estimations arose from insufficiently considered
information in landmarking.
4.2.2 Case 2: Misspecification of the dependence function
To investigate a misspecification of the dependence structure, we used the same generated data as in
case 1 but the prediction models neglected the slope of the marker in the estimation and prediction steps
although marker slope had a strong impact on the risk of recurrence.
The distributions over the replicates of the differences of MSEP for all the selected pairs of landmark
and horizon times are depicted in Figure 4. Estimators behave similarly as in case 1 relative to the
JM marginal estimator. However, neglecting the slope in the dependence structure induced a large
increase in the MSEP of the JM marginal estimator (given by ref in Figure 3 and Figure 4); for instance,
for (s,w) = (1, 3), the MSEP increases from 0.323 to 1.114. This underlines the great importance of
correctly specifying the dependence function in these models. The examination of AUC differences
(Figure 7 in Supplementary Material) led to the same conclusions, except that the AUC under case 1
was not systematically better than the one under case 2.
4.2.3 Case 3: Violation of the proportional hazards assumption
The robustness of the models to a violation of the proportional hazard assumption was checked by
considering an interaction with log(1+t) for the survival parameters associated with the marker dynamics
in the generation model (see Section 3.2 of the Supplementary Material for the model specification).
For all the prediction models, the estimation and prediction steps did not consider this interaction with
log(1 + t).
Boxplots of the differences of MSEP over the replicates are depicted in Figure 5. Even under this
strong violation of the PH assumption, the performances of the two-stage landmark and joint models
remained comparable. Indeed, although the landmark model permitted to obtain estimated parameters
closer to the generated one, their variances were very large because of the much reduced information
used in these models (see Figure 2 in Supplementary Material for an illustration of the estimators be-
havior). One can also note that the pseudo-value approach was not better than the models based on
proportional hazards. Again, the same conclusions were drawn from the differences in AUC (Figure 8
in Supplementary Material).
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4.2.4 Case 4: Misspecification of the longitudinal trajectory of the marker
The last case explored the performances of the prediction models when the longitudinal trend of the
marker was misspecified. Data were generated using a joint model with a biphasic shape of the marker
as generally observed for PSA data, whereas a linear trajectory over time for the marker was considered
for the estimation of the predicted probabilities of event using joint and two-stage landmark models (see
Section 3.3 of the Supplementary Material for the model specification). The degree of misspecification
of the longitudinal marker trend (shown in Figure 3 of the Supplementary Material) was chosen to be
severe to clearly show the impact of such misspecification.
Figure 6 displays the boxplots of differences in MSEP for the 8 pairs (s,w). The landmark models
performed much better than the joint models for landmark times s = 1, 3, 5; at landmark time s = 8,
performances of joint and landmark models became roughly similar. Such result was expected. The
joint model incorrectly assumed a linear trajectory for the marker on the whole follow-up while the
landmark model, by considering only the longitudinal information collected until s, assumed a linear
trajectory only until s which was more realistic at earliest landmark times even if still far from being
well specified. The same conclusions were drawn from the examination of the AUC differences (Figure 9
in Supplementary Material), except that even at the latest landmark time (8 years), the landmark models
remained much more discriminatory than the joint model.
To explore whether such differences were due to the severe misspecification of our example, we
considered a second longitudinal marker trend (see Section 2.1 of the Supplementary Material for model
specification). This supplementary case considered a small degree of misspecification of the longitu-
dinal marker by considering some slight fluctuations with splines in the generation model compared to
the well-specified case 1. Although only slightly misspecified, the superiority of joint model over land-
mark approaches previously found in case 1 almost completely disappeared. This confirmed the high
sensitivity to any kind of misspecification of the marker trajectory in the joint model.
5 Discussion
With the development of personalized medicine, it is important to provide valid and powerful tools to
clinicians for the computation of individual probabilities of specific events such as landmark conditional
cumulative probabilities. These predictions are expected to be used in clinical practice, notably to adapt
individual strategies of treatment or to plan the patient-specific optimal screening time in clinical trials.
Several authors (Maziarz et al., 2017; Rizopoulos, 2011) already proposed estimators of the indi-
vidual conditional cumulative probability pik?(s,w), but none was formally validated. Our first objective
was thus to precisely define the quantity of interest pik?(s,w) and provide estimators (along with 95%
confidence interval) both for the landmarking and the joint modelling approaches and properly validate
them by comparing generated and estimated expressions of pik?(s,w). The generated pi
k
?(s,w) was not
obvious to compute as involving an integral over the latent structure shared by the longitudinal and
survival processes, the data being generated from a joint model. Note that such quantity is not always
correctly defined (e.g., (Barrett and Su, 2017; Rizopoulos et al., 2017)). The marginal estimator from
the joint model obtained very good performance in general whereas the conditional estimator from the
joint model was found to necessitate substantial individual longitudinal information collected until the
prediction time to be accurate.
Quantification of the uncertainty around individual predictions is essential for the decision making
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in clinical practice. In the landmark approach no solution was ever proposed, and a vagueness pre-
vailed in the joint modelling literature with some definitions conditional on the marker’s observations
(Maziarz et al., 2017; Proust-Lima and Taylor, 2009; Taylor et al., 2013), others taking into account the
measurement error in the marker’s observations either along with the population parameter uncertainty
(Rizopoulos, 2011; Yu et al., 2008) or without (Desme´e et al., 2017). Since we defined a quantity of
interest conditional on the marker’s observations, our definitions of uncertainty only took into account
the variability due to parameter estimates. We proposed corresponding Monte Carlo methods to com-
pute the confidence intervals of the predictions in a unified manner for joint and landmark models and
we showed that they correctly assessed the uncertainty around the individual predictions using a simula-
tion study. Compared to the joint model, the estimator based on the two-stage landmark cause-specific
proportional hazards model confirmed its expected poor efficiency, with wide confidence intervals when
only a few subjects experienced the event in the prediction window.
Our second objective was to properly compare the landmark models and the joint model through
several cases of well- and mis-specification. Indeed, a series of papers showed comparisons of predic-
tion models in dynamic predictions (Goldstein et al., 2017; Huang et al., 2016; Sweeting et al., 2017)
but none of them evaluated their robustness to misspecifications although most proposed methods were
parametric. To our knowledge, only one contribution explored the problem of misspecification of predic-
tion models (only longitudinal trajectory and functional dependency) very recently in a small simulation
study and concluded to the superiority of joint models approach over landmark models (Rizopoulos
et al., 2017).
In our extensive simulation study, we found that in the case of correctly specified model, the joint
model performed better than the landmark models, as expected. In the case of misspecification of the
dependence structure between the longitudinal process and the survival process, the difference of perfor-
mances between approaches did not change as also concluded by Rizopoulos et al. (2017) Rizopoulos
et al. (2017). But more importantly, the performances of misspecified models (both from joint mod-
elling and landmarking approaches were much worse in terms of prediction error. Regarding the PH
assumption, the two landmark models we proposed better dealt with this assumption than the joint
model: dynamic pseudo-values did not require the PH assumption at all, and our cause-specific hazards
landmark models limited the PH assumption to the prediction window with an administrative censoring
at the end of it. Yet, the impact of PH assumption violation on the estimators derived from the joint
model remained limited, suggesting that the violation of the PH assumption should be extreme to entail
a tangible impact on the estimated cumulative probabilities in the joint model. Finally, we showed that
the correct specification of the marker trajectory was essential to provide good predictions with joint
models (and with landmark models to a much lesser extent). We demonstrated the major loss of per-
formance of the joint model in a severe case of misspecification to illustrate the limit but we also found
in Supplementary Material that even a slight misspecification of the trajectory (usually considered as
acceptable) impacted the prediction error of the models, and eliminated for example the gain of using
the joint model over the landmark model at shorter landmark times or when the horizon time increased.
As usual in prediction model development, comparisons were made in terms of both Mean Square
Error of Prediction which measures a trade-off between calibration and discrimination, and Area Under
the ROC Curve which only targets discriminatory power. With the perspective in mind of providing
quantified individual predictions, we chose to primarily rely on the prediction error even though most
conclusions were also drawn from AUC examinations, yet sometimes to a lesser extent. This was proba-
bly explained by the lesser sensitivity of AUC (Pencina et al., 2008) and the possibly preserved discrim-
inatory power in the presence of worse calibration.
14
To conclude with recommendations, we emphasize the need to carefully define the quantity of inter-
est, its estimator and the type of associated uncertainty. The several cases of misspecification warned us
on the necessity to precisely specify the dependence structure between the longitudinal marker dynamics
and the risk of event, and not systematically consider only the current marker level. Finally, the specifi-
cation of the longitudinal marker trend should be studied with extreme care, especially when using joint
models. Researchers should be warned that the use of sophisticated methods such as the joint models
may allow obtaining accurate and efficient estimators only when they are correctly specified. Otherwise,
estimators might be off the mark. Landmark models seem less sensitive to the misspecification of the
longitudinal marker trajectory but they are as sensitive as joint models regarding the misspecification of
the dependence structure. In addition, they provide considerably less efficient estimators and may induce
convergence problems, notably when the landmark time increases and thus the considered information
becomes too poor.
6 Supplementary Material
An Appendix may be found in the source package of this article on arXiv. Detailed examples of the code
can be found at https://github.com/LoicFerrer for practical use.
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(a) Patient A: Cohort = RTOG 9406, Age = 72, Tstage = 2, Gleason = 6 and Initial logPSA = 0.74.
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(b) Patient B: Cohort = RTOG 9406, Age = 69, Tstage = 3, Gleason = 7 and Initial logPSA = 2.07.
Figure 1 – Predicted individual cumulative probabilities of prostate cancer recurrence before death in
two selected patients with a localized prostate cancer treated by radiotherapy (patient A for top panels
and patient B for bottom panels). The predictions are computed from the log-levels of PSA collected
until landmark time (×) and baseline information using the marginal and conditional estimators from the
joint model (JM-marg and JM-cond, respectively), the cause-specific landmark models with a naive or
two-stage approach (Naive-LM-PH and 2s-LM-PH, respectively) and the two-stage pseudo-value model
(2s-LM-PV). For each subject, the probabilities are computed from two landmark times (plain grey lines
at 1.3 or 1.5 for left panels and 2.5 for right panels and for two prediction windows w = 1.5 and w = 3
(dotted blue and red lines, respectively). The associated 95% confidence intervals are obtained using
500 bootstrap samples.
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(a) Evaluation of the estimators: distribution over the individuals ? = 1, . . . ,N(s) of the relative bias (RB,
in %). The dashed line represents the 0.
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(b) Evaluation of the confidence intervals: distribution over the individuals ? = 1, . . . , 200 of the coverage
rates (CR) for the 95% confidence intervals of piRec.? (s,w; θ). The dashed line represents the 0.95.
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(c) Evaluation of the estimator efficiency: distribution over the individuals ? = 1, . . . , 200 of the mean 95%
confidence interval widths (|CI|).
Figure 2 – Evaluation of the estimators in terms of relative bias (a), coverage rates (b) and confidence
intervals widths (c). Considered are the marginal estimator and the conditional estimator from the joint
model (denoted JM-marg and JM-cond, respectively) and the estimator based on the two-stage cause-
specific landmark model (denoted 2s-LM-PH).
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Figure 3 – Boxplots of the differences (×1000) of Mean Square Error of Prediction (MSEP) between
the marginal estimator from the joint model (denoted JM-marg) and alternatives in the case of correct
specification of the joint model (case 1). Considered are the conditional estimator from the joint model
(JM-cond), the estimators from cause-specific landmark models using a two-stage or naive approach
(2s-LM-PH and Naive-LM-PH, respectively) and the two-stage pseudo value model (2s-LM-PV). Only
models that converged were considered. The distributions are depicted over R = 499, 494, 486, 389
replicates for 4 landmark times s = 1, 3, 5, 8 respectively, with 2 considered horizons w = 1.5 and
w = 3. ref denotes the mean MSEP (×1000) using the marginal estimator from the joint model for each
(s,w). See the mean sample sizes and the mean number of recurrences occurred between s and s + w in
Table 1 of the Supplementary Material.
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Figure 4 – Boxplots of the differences (×1000) of Mean Square Error of Prediction (MSEP) between the
marginal estimator from the joint model (denoted JM-marg) and alternatives in the case of misspecifica-
tion of the dependence function (case 2). Considered are the conditional estimator from the joint model
(JM-cond), the estimators from cause-specific landmark models using a two-stage or naive approach
(2s-LM-PH and Naive-LM-PH, respectively) and the two-stage pseudo value model (2s-LM-PV). Only
models that converged were considered. The distributions are depicted over R = 499, 498, 497, 428
replicates for 4 landmark times s = 1, 3, 5, 8 respectively, with 2 considered horizons w = 1.5 and
w = 3. ref denotes the mean MSEP (×1000) using the marginal estimator from the joint model for each
(s,w). See the mean sample sizes and the mean number of recurrences occurred between s and s + w in
Table 1 of the Supplementary Material.
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Figure 5 – Boxplots of the differences (×1000) of Mean Square Error of Prediction (MSEP) between the
marginal estimator from the joint model (denoted JM-marg) and alternatives in the case of substantial
violation of the PH assumption (case 3). Considered are the conditional estimator from the joint model
(JM-cond), the estimators from cause-specific landmark models using a two-stage or naive approach
(2s-LM-PH and Naive-LM-PH, respectively) and the two-stage pseudo value model (2s-LM-PV). Only
models that converged were considered. The distributions are depicted over R = 485, 326, 294, 188
replicates for 4 landmark times s = 1, 3, 5, 8 respectively, with 2 considered horizons w = 1.5 and
w = 3. ref denotes the mean MSEP (×1000) using the marginal estimator from the joint model for each
(s,w). See the mean sample sizes and the mean number of recurrences occurred between s and s + w in
Table 1 of the Supplementary Material.
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Figure 6 – Boxplots of the differences (×1000) of Mean Square Error of Prediction (MSEP) between the
marginal estimator from the joint model (denoted JM-marg) and alternatives in the case of substantial
misspecification of the longitudinal marker trajectory (case 4). Considered are the conditional estimator
from the joint model (JM-cond), the estimators from cause-specific landmark models using a two-stage
or naive approach (2s-LM-PH and Naive-LM-PH, respectively) and the two-stage pseudo value model
(2s-LM-PV). Only models that converged were considered. The distributions are depicted over R =
500, 496, 476, 357 replicates for 4 landmark times s = 1, 3, 5, 8 respectively, with 2 considered horizons
w = 1.5 and w = 3. ref denotes the mean MSEP (×1000) using the marginal estimator from the joint
model for each (s,w). See the mean sample sizes and the mean number of recurrences occurred between
s and s + w in Table 1 of the Supplementary Material.
